A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients

Clinical Cancer Research

Volumn 3, Issue 2, 1997, Pages 221-226

  Scheibenbogen, Carmen ^a,e   Lee, Kang Hun ^a   Mayer, Stefanie ^a   Stevanovic, Stefan ^b   Moebius, Ulrich ^c   Herr, Wolfgang ^d   Rammensee, Hans Georg ^b   Keilholz, Ulrich ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e Medizinische Klinik und Poliklinik V   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD8 ANTIGEN; EPITOPE; HLA A ANTIGEN; PEPTIDE; VIRUS PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFLUENZA VIRUS; MELANOMA; PRIORITY JOURNAL; QUANTITATIVE ASSAY; T LYMPHOCYTE;

CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A1 ANTIGEN; HLA-A3 ANTIGEN; HUMANS; IMMUNOASSAY; INTERFERON TYPE II; INTERFERON-GAMMA; MELANOMA; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE; PEPTIDES; T-LYMPHOCYTE SUBSETS; VIRAL PROTEINS;

EID: 0031027541     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Boon, T., Gajewski, T. F., and Coulie, P. From defined tumor antigens to effective immunization? Immunol. Today, 16: 334-336, 1995.
2. Cerrotini, J. C., and Brunner, K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv. Immunol., 18: 67-132, 1974.
3. Taswell, C. Limiting dilution assays for the determination of immu- nocompetent cell frequencies. I. Data analysis. J. Immunol., 126: 614-619, 1981.
4. Hecht, T. T., Longo, D. L., and Matis, L. A. The relationship between immune interferon production and proliferation in antigen-specific MHC-restricted T cell lines and clones. J. Immunol., 131: 1049-1055, 1983.
5. Horn, S., Schwartzentruber, D. J., Rosenberg, S. A., and Topalian, S. L. Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens. J. Immunother., 13: 18-30, 1993.
6. Mayer, S., Scheibenbogen, C., Lee, K-H., Keilholz, W., Stevanovic, S., Rammensee, H-G., and Keilholz, U. A sensitive proliferation assay to determine a specific T-cell response against an HLA-A2.1-binding peptide. J. Immunol. Methods, 797: 131-137, 1996.
7. Czerkinsky, C. C., Andersson, G., and Ekre, H. P. Reverse ELISPOT assay for clonal analysis of cytokine production. Enumeration of gamma-interferon secreting cells. J. Immunol. Methods, 110: 29-36, 1988.
8. Bednarek, M. A., Sauma, S. Y., Gammon, M. C., Porter, G., Tamhankar, S., Williamson, A. R., and Zweerink, H. The minimum peptide epitope from the influenza virus matrix protein. J. Immunol., 147: 4047-4053, 1991.
9. Walker, B. D., Flexner, C., Birch-Limberger, K., Fisher, L., Paradis, T. J., Aldovini, A., Young, R., Moss, B., and Schooley, R. T. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with HIV type. Proc. Natl. Acad. Sci. USA, 86: 9514-9518, 1989.
10. DiBrino, M., Tsuchida, T., Turner, R. V., Parker, K. C., Coligan, J. E., and Biddison, W. E. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J. Immunol., 151: 5930-5935, 1993.
11. Keilholz, U., Scheibenbogen, C. Tilgen, W., Bergmann, L., Weidmann, E., Seither, E., Richter, M., Brado, B., Mitrou, P. S., and Hunstein, W. Interferon-α and interieukin-2 in the treatment of malignant melanoma: a comparison of two phase II trials. Cancer (Phila.), 72: 607-614, 1993.
12. Keilholz, U., Goey, S. H., Punt, C. J. A., Proebstle, T., Salzmann, E., Schadendorf, D., Lienard, D., Scheibenbogen, C., Eggermont, A. M. M. A randomized trial of IFNα/IL-2 vs. IFNα/IL-2 + CDDP in advanced melanoma: an EORTC melanoma cooperative group trial. Proc. Am. Soc. Clin. Oncol., 15: 436, 1996.
13. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgalier, M. L., Yanelli, J. R., Apella E., and Rosenberg, S. A. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154: 2257-2265, 1995.
14. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G., and Rammensee, H-G. Allele specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.), 351: 290-296, 1991.
15. Salter, R. D., Howell, D. N., and Cresswell, P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics, 21: 235-246, 1985.
16. Herr, W., Schneider, J., Lohse, A. W., Meyer zum Büschenfelde, K-H., Wölfel, W. Detection and quantification of blood-derived CD8 + T lymphocytes secreting tumor necrosis factor a in response to HLA-A2.1-binding melanoma and viral peptide antigens. J. Immunol. Methods, 191: 131-143, 1996.
17. Mosmann, T. R., and Sad S. The expanding universe of T cell subsets: Th1. Th2 and more. Immunol. Today, 17: 138-146, 1996.
18. Miyahira, Y., Murata, K., Rodriguez, D., Rodriguez, J. R., Esteban, M., Rodrigues, M. M., and Zavala, F. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J. Immunol. Methods, 181: 45-54, 1995.
19. Di Fabio, S., Mbawuike, I. N., Kiyono, H., Fujihashi, K., Couch, R., and McGhee, J. R. Quantification of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-γ producing CD8+ T cells. Int. Immunol., 6: 11-19, 1993.
20. Tanguay, S., and Killion, J. J. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine secreting cells. Lymphokine Cytokine Res., 13: 259-263, 1994.
21. Barouch, D., Friede, T., Stevanovic, S., Tussey, L., Smith, K., Rowland-Jones, S., Braud, V., McMicheal, A., and Rammensee, H-G. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med., 182: 1847-1856, 1995.
22. Cerny, A., McHutchinson, J. G., Pasquinelli, C., Brown, M. E., Brothers, M. A., Grabscheid, B., Fowler, P., Houghton, M., and Chisari, F. V. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1-binding motif. J. Clin. Invest., 95: 521-530, 1995.
23. Gotch, F. M., McMicheal, M., Smith, A. J., and Moss, B. Identification of the viral molecules recognized by influenza specific human cytotoxic T lymphocytes. J. Exp. Med., 165: 408-416, 1986.
24. Rammensee, H-G., Friede, T., and Stevanovic, S. MHC ligands and peptide motifs: first listing. Immunogenetics, 41: 178-228, 1995.
25. Zier, K., Gansbacher, B., and Salvadori. S. Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol. Today, 17: 39-45, 1996.